Close

Diplomat Pharmacy (DPLO) Says It's Dispensing MAVYRET to Treat Chronic Hepatitis C

August 17, 2017 4:36 PM EDT Send to a Friend
Diplomat Pharmacy, Inc. (NYSE: DPLO), is dispensing newly approved MAVYRET™ (glecaprevir and pibrentasvir) oral tablets for chronic hepatitis C ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login